GLP-1 drugs are not the first class of medications to create this tension, and they will not be the last
The next phase of the case will focus on collecting the damages awarded
Dhanapalaratnam R, Issar T, Lee ATK, Poynten AM, Milner KL, Kwai NCG, Krishnan AV (2024) Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy
Quality of Care: Check out customer reviews and satisfaction scores
The most important intervention to support growth is optimizing nutritional support during GLP-1 treatment, he says
Last reviewed: June 8, 2026 Last updated: June 8, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations